To characterize sequence variation within the glucocerebrosidase (GBA) gene in a select subset of our sample of patients with familial Parkinson disease (PD) and then to test in our full sample whether these sequence variants increased the risk for PD and were associated with an earlier onset of disease.
No takes yet. Share an insight, caveat, or question.
Sidransky et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: